Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melody Perpich

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Pediatrics|December 23, 2017
Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago ExperienceAmi V Desai, Melody Perpich, Lucy A Godley
Pathology Research International|February 19, 2011
Hereditary diffuse gastric cancer: multidisciplinary case report with review of the literatureRebecca Wilcox, Melody Perpich, Amy Noffsinger, et al.
Journal of Genetic Counseling|October 19, 2020
Parental attitudes regarding the need for genetic services in a pediatric brain tumor survivorship programAlice Zalan, Tara Maga, Melody Perpich, et al.
Gynecologic Oncology Reports|July 18, 2018
Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndromeMatthew Cowan, Tara Suntum, Andrea D Olivas, et al.
Iscience|January 23, 2025
Germline predisposition in multiple myelomaFernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The ENGAGE Study: A Randomized Trial Optimizing Uptake of Germline Cancer Genetic Services in Childhood Cancer SurvivorsTara O Henderson, Brian Egleston, Sarah Howe, et al.
Lancet Regional Health. Americas|March 23, 2026
The ENGAGE study: a randomized trial optimizing uptake of germline cancer genetic services in childhood cancer survivorsTara O Henderson, Brian Egleston, Sarah Howe, et al.
Haematologica|February 13, 2025
Overall cancer risk in people with deleterious germline <i>DDX41</i> variantsSophia C Korotev, Jason X Cheng, Yogameenakshi Haribabu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Pediatrics|December 23, 2017
Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago ExperienceAmi V Desai, Melody Perpich, Lucy A Godley
Pathology Research International|February 19, 2011
Hereditary diffuse gastric cancer: multidisciplinary case report with review of the literatureRebecca Wilcox, Melody Perpich, Amy Noffsinger, et al.
Journal of Genetic Counseling|October 19, 2020
Parental attitudes regarding the need for genetic services in a pediatric brain tumor survivorship programAlice Zalan, Tara Maga, Melody Perpich, et al.
Gynecologic Oncology Reports|July 18, 2018
Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndromeMatthew Cowan, Tara Suntum, Andrea D Olivas, et al.
Iscience|January 23, 2025
Germline predisposition in multiple myelomaFernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The ENGAGE Study: A Randomized Trial Optimizing Uptake of Germline Cancer Genetic Services in Childhood Cancer SurvivorsTara O Henderson, Brian Egleston, Sarah Howe, et al.
Lancet Regional Health. Americas|March 23, 2026
The ENGAGE study: a randomized trial optimizing uptake of germline cancer genetic services in childhood cancer survivorsTara O Henderson, Brian Egleston, Sarah Howe, et al.
Haematologica|February 13, 2025
Overall cancer risk in people with deleterious germline <i>DDX41</i> variantsSophia C Korotev, Jason X Cheng, Yogameenakshi Haribabu, et al.
Pageof 1